Health Care & Life Sciences » Pharmaceuticals | Hwail Pharmaceutical Co. Ltd.

Hwail Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
10,207
9,217
6,650
10,048
18,219
Total Accounts Receivable
34,767
38,664
42,295
41,078
36,860
Inventories
26,931
25,942
31,933
24,803
23,963
Other Current Assets
798
238
140
195
68
Total Current Assets
72,703
74,062
81,017
76,124
79,110
Net Property, Plant & Equipment
38,907
39,040
37,654
35,688
34,031
Total Investments and Advances
6,928
5,010
16,762
12,317
4,982
Long-Term Note Receivable
105
-
3
8
3
Intangible Assets
4,194
4,813
4,835
4,171
3,615
Other Assets
188
-
-
308
436
Total Assets
123,024
122,924
140,272
128,616
123,903
ST Debt & Current Portion LT Debt
11,927
13,228
21,734
9,367
9,386
Accounts Payable
5,105
6,777
6,476
5,755
4,888
Income Tax Payable
657
289
1,550
2,515
1,428
Other Current Liabilities
7,703
1,568
3,730
1,532
1,989
Total Current Liabilities
25,392
21,862
33,491
19,169
17,692
Long-Term Debt
9,790
8,435
5,081
5,726
4,371
Provision for Risks & Charges
2
1
-
-
20
Deferred Taxes
1,530
1,179
2,757
326
1,727
Other Liabilities
-
2,378
-
3,534
3,642
Total Liabilities
36,715
33,854
41,328
28,755
25,725
Common Equity (Total)
86,309
89,070
98,944
99,861
98,179
Total Shareholders' Equity
86,309
89,070
98,944
99,861
98,179
Total Equity
86,309
89,070
98,944
99,861
98,179
Liabilities & Shareholders' Equity
123,024
122,924
140,272
128,616
123,903

About Hwail Pharmaceutical Co.

View Profile
Address
57 Jeyakgongdan 3-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.hwail.com
Updated 09/14/2018
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others.